Evidence map›Paper›PMID 38616337›Full record

ArticleMovement disorders clinical practice2024

Reply to: Partially Levodopa-Responsive Parkinsonism in a Carrier of a Novel Pathogenic CLTC Variant.

Francesca Nardecchia, Simone Martinelli, Luca Pollini, Vincenzo Leuzzi

Open access · greenAbstract readLetter
In one paragraph

Article in Movement disorders clinical practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Francesca NardecchiaDepartment of Human Neuroscience, Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-0808-2827
Simone MartinelliDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Luca PolliniDepartment of Human Neuroscience, Sapienza University of Rome, Rome, Italy.ORCID 0000-0001-9634-6572
Vincenzo LeuzziDepartment of Human Neuroscience, Sapienza University of Rome, Rome, Italy.
Sapienza University of Rome · ITFondazione Santa Lucia · ITIstituto Superiore di Sanità · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LevodopaParkinsonian DisordersAntiparkinson AgentsHumansAntiparkinson AgentsLevodopaclathrinCLTCmovement disordersneurodevelopmental disordersparkinsonism

Identifiers

PMID38616337
PMCPMC11145133
OpenAlexW4394817715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.